61 related articles for article (PubMed ID: 12236035)
1. [Normal urinary levels of telopeptide aminoterminal (NTx) of type I collagen in healthy term newborns and infants in the first month of life].
Praticò G; Palano GM; Curreri R; D'Agata A; Carpinato C; Sottile F; Sorge A
Pediatr Med Chir; 2002; 24(3):213-6. PubMed ID: 12236035
[TBL] [Abstract][Full Text] [Related]
2. [Normal urine levels of the aminoterminal telopeptide of type I collagen (NTx) in premature newborns in the first week of life].
Praticò G; Palano GM; Curreri R; Marletta M; Parisi G; Praticò ER
Pediatr Med Chir; 2005; 27(1-2):81-5. PubMed ID: 16922049
[TBL] [Abstract][Full Text] [Related]
3. [Normal levels of collagen-type-I telopeptide in the first 90 days of life].
Praticò G; Caltabiano L; Palano GM; Zingale A
Pediatr Med Chir; 1998; 20(3):193-5. PubMed ID: 9744011
[TBL] [Abstract][Full Text] [Related]
4. Urinary cross-linked N-telopeptides of type I collagen and bone metabolic diseases.
Xue Y; Jia W; Zhang H; Dong J; Clemens JD; Tian X
Chin Med J (Engl); 1999 Feb; 112(2):149-52. PubMed ID: 11593583
[TBL] [Abstract][Full Text] [Related]
5. Effect of bed rest during pregnancy on bone turnover markers in pregnant and postpartum women.
Kaji T; Yasui T; Suto M; Mitani R; Morine M; Uemura H; Maeda K; Irahara M
Bone; 2007 Apr; 40(4):1088-94. PubMed ID: 17229597
[TBL] [Abstract][Full Text] [Related]
6. Urinary NTX results rarely alter the clinical management of patients with osteoporosis in the tertiary hospital.
Gillett MJ; Vasikaran SD
Pathology; 2006 Feb; 38(1):49-52. PubMed ID: 16484009
[TBL] [Abstract][Full Text] [Related]
7. Bone turnover in neonates: changes of urinary excretion rate of collagen type I cross-linked peptides during the first days of life and influence of gestational age.
Mora S; Prinster C; Bellini A; Weber G; Proverbio MC; Puzzovio M; Bianchi C; Chiumello G
Bone; 1997 Jun; 20(6):563-6. PubMed ID: 9177872
[TBL] [Abstract][Full Text] [Related]
8. A comparison of methods for measuring serum and urinary markers of bone metabolism in cats.
DeLaurier A; Jackson B; Pfeiffer D; Ingham K; Horton MA; Price JS
Res Vet Sci; 2004 Aug; 77(1):29-39. PubMed ID: 15120950
[TBL] [Abstract][Full Text] [Related]
9. Early changes in urinary cross-linked N-terminal telopeptides of type I collagen level correlate with 1-year response of lumbar bone mineral density to alendronate in postmenopausal Japanese women with osteoporosis.
Iwamoto J; Takeda T; Sato Y; Uzawa M
J Bone Miner Metab; 2005; 23(3):238-42. PubMed ID: 15838627
[TBL] [Abstract][Full Text] [Related]
10. Urinary type II collagen helical peptide (HELIX-II) as a new biochemical marker of cartilage degradation in patients with osteoarthritis and rheumatoid arthritis.
Charni N; Juillet F; Garnero P
Arthritis Rheum; 2005 Apr; 52(4):1081-90. PubMed ID: 15818703
[TBL] [Abstract][Full Text] [Related]
11. Clinical value of bone remodelling markers in patients with bone metastases treated with zoledronic acid.
Pectasides D; Nikolaou M; Farmakis D; Kanakis I; Gaglia A; Kountourakis P; Karamanos NK; Economopoulos T; Raptis SA
Anticancer Res; 2005; 25(2B):1457-63. PubMed ID: 15865105
[TBL] [Abstract][Full Text] [Related]
12. Assessment of urinary N-telopeptide: point-of-care testing, sample types, and relationship to urinary helical peptide excretion.
Zwart SR; DeKerlegand DE; Davis-Street JE; Smith SM
Clin Chim Acta; 2006 Oct; 372(1-2):65-9. PubMed ID: 16678144
[TBL] [Abstract][Full Text] [Related]
13. A cross-sectional study of bone turnover markers in healthy premenopausal women.
de Papp AE; Bone HG; Caulfield MP; Kagan R; Buinewicz A; Chen E; Rosenberg E; Reitz RE
Bone; 2007 May; 40(5):1222-30. PubMed ID: 17331821
[TBL] [Abstract][Full Text] [Related]
14. Feto-maternal bone remodeling in normal pregnancy and preeclampsia.
Shaarawy M; Zaki S; Ramzi AM; Salem ME; El-Minawi AM
J Soc Gynecol Investig; 2005 Jul; 12(5):343-8. PubMed ID: 15979546
[TBL] [Abstract][Full Text] [Related]
15. Urinary markers of altered collagen metabolism in fibromyalgia patients.
Ribel-Madsen S; Christgau S; Gronemann ST; Bartels EM; Danneskiold-Samsøe B; Bliddal H
Scand J Rheumatol; 2007; 36(6):470-7. PubMed ID: 18092271
[TBL] [Abstract][Full Text] [Related]
16. Determination of NTx in second-morning urine: a proposal for the standardization of morning urine collection.
Wendlová J; Mikulecký M
Wien Med Wochenschr; 2001; 151(18-20):472-5. PubMed ID: 11817260
[TBL] [Abstract][Full Text] [Related]
17. A single zoledronic acid infusion reduces bone resorption markers more rapidly than weekly oral alendronate in postmenopausal women with low bone mineral density.
Saag K; Lindsay R; Kriegman A; Beamer E; Zhou W
Bone; 2007 May; 40(5):1238-43. PubMed ID: 17347063
[TBL] [Abstract][Full Text] [Related]
18. Urinary excretion of cross-linked N-telopeptides of type 1 collagen to assess bone resorption in infants from birth to 1 year of age.
Lapillonne A; Travers R; DiMaio M; Salle BL; Glorieux FH
Pediatrics; 2002 Jul; 110(1 Pt 1):105-9. PubMed ID: 12093954
[TBL] [Abstract][Full Text] [Related]
19. Cross-linked N-telopeptide of type I collagen (NTx) in urine as a predictor of periprosthetic osteolysis.
von Schewelov T; Carlsson A; Dahlberg L
J Orthop Res; 2006 Jul; 24(7):1342-8. PubMed ID: 16718682
[TBL] [Abstract][Full Text] [Related]
20. First-line therapy with thalidomide, dexamethasone and zoledronic acid decreases bone resorption markers in patients with multiple myeloma.
Tosi P; Zamagni E; Cellini C; Parente R; Cangini D; Tacchetti P; Perrone G; Ceccolini M; Boni P; Tura S; Baccarani M; Cavo M
Eur J Haematol; 2006 May; 76(5):399-404. PubMed ID: 16480429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
